Translate
Precision Biosciences Inc
About
Precision Biosciences Inc (NASDAQ:DTIL) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026
Apr 15 2026
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Apr 8 2026
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
Mar 12 2026
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update
Mar 11 2026
Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Recent Videos
Precision BioSciences PBGENE-DMD and FUNCTION-DMD Investor Update | March 17, 2026
Mar 18, 2026
Precision Reports Fourth Quarter and Fiscal Year 2025 Financial Results & Provides Business Update
Mar 13, 2026
Precision Bio-Tech & Medical Packaging Solutions
Jan 31, 2026
Precision Bio-Equipment
Jan 10, 2026